Home > Articles > Search Results: Montalban, Xavier

Articles

  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Articles 109 records found  previous11 - 20nextend  jump to record: Search took 0.01 seconds. 
11.
17 p, 300.8 KB Expert opinion on the use of cladribine tablets in clinical practice / Sørensen, Per Soelberg (University of Copenhagen) ; Centonze, Diego (Unit of Neurology and Neurorehabilitation) ; Giovannoni, Gavin (Queen Mary University of London) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Selchen, Daniel (St. Michael's Hospital, Toronto) ; Vermersch, Patrick (Univ. Lille) ; Wiendl, Heinz (University of Münster) ; Yamout, Bassem (American University of Beirut) ; Salloukh, Hashem (Ares Trading S.A. Merck Serono S.A) ; Rieckmann, Peter (University of Erlangen) ; Universitat Autònoma de Barcelona. Departament de Medicina
Background: Gaps in current product labels and a lack of detailed clinical guidelines leaves clinicians' questions on the practical management of patients receiving cladribine tablets for the treatment of relapsing multiple sclerosis (MS) unanswered. [...]
2020 - 10.1177/1756286420935019
Therapeutic Advances in Neurological Disorders, Vol. 13 (2020)  
Detailed record - Creative Commons
12.
15 p, 1.4 MB Critical role of interleukin (IL)-17 in inflammatory and immune disorders : An updated review of the evidence focusing in controversies / Ruiz de Morales, José María G. (Universidad de León) ; Puig, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina) ; Daudén, Esteban (Hospital Universitario de la Princesa (Madrid)) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Pablos, José Luis (Hospital Universitario 12 de Octubre (Madrid)) ; Martín, Antonio Oliveira (Hospital Universitario La Paz (Madrid)) ; Juanatey, Carlos González (Hospital Universitario Lucus Augusti (Lugo)) ; Adan Civera, Alfredo (Hospital Clínic i Provincial de Barcelona) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Borruel, Natalia (Hospital Universitari Vall d'Hebron) ; Ortí, Guillermo (Vall d'Hebron Institut d'Oncologia) ; Holgado-Martín, Esther (Ruber Internacional) ; Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ; Vizcaya-Morales, Cynthia (Novartis Pharma) ; Martín-Vázquez, Víctor (Novartis Farmacéutica) ; González-Gay, Miguel Ángel (Universidad de Cantabria)
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive research because of its crucial role in the pathogenesis of different diseases across many medical specialties. [...]
2020 - 10.1016/j.autrev.2019.102429
Autoimmunity Reviews, Vol. 19 Núm. 1 (january 2020) , p. 102429  
Detailed record - Creative Commons
13.
12 p, 888.5 KB Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis / Turner, Benjamin (The Royal London Hospital) ; Cree, Bruce A. C (University of California) ; Kappos, Ludwig (University Hospital Basel (Basilea, Suïssa)) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Papeix, Caroline (Pitié-Salpêtrière Hospital) ; Wolinsky, Jerry S. (The University of Texas Health Science Center at Houston (UTHealth)) ; Buffels, Regine (F. Hoffmann-La Roche Ltd) ; Fiore, Damian (Genentech. Inc) ; Garren, Hideki (Genentech. Inc) ; Han, Jian (Genentech. Inc) ; Hauser, Stephen L. (University of California) ; Universitat Autònoma de Barcelona. Departament de Medicina
Objective: The efficacy and safety of ocrelizumab, versus interferon (IFN) β-1a, for the treatment of relapsing multiple sclerosis (RMS) from the identically designed OPERA I (NCT01247324) and OPERA II (NCT01412333) phase III studies has been reported; here we present subgroup analyses of efficacy endpoints from the pooled OPERA I and OPERA II populations. [...]
2019 - 10.1007/s00415-019-09248-6
Journal of Neurology, Vol. 266 Núm. 5 (may 2019) , p. 1182-1193  
Detailed record - Creative Commons
14.
14 p, 1.2 MB Safety of Ocrelizumab in Patients with Relapsing and Primary Progressive Multiple Sclerosis / Hauser, Stephen L. (University of California) ; Kappos, Ludwig (University of Basel) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Craveiro, Licinio (F. Hoffmann-La Roche Ltd.) ; Chognot, Cathy (F. Hoffmann-La Roche Ltd.) ; Hughes, Richard (F. Hoffmann-La Roche Ltd.) ; Koendgen, Harold (F. Hoffmann-La Roche Ltd.) ; Pasquarelli, Noemi (F. Hoffmann-La Roche Ltd.) ; Pradhan, Ashish (Genentech Inc.) ; Prajapati, Kalpesh (IQVIA Solutions Inc.) ; Wolinsky, Jerry S. (Health Science Center at Houston) ; Universitat Autònoma de Barcelona
Background and Objectives To report safety of ocrelizumab (OCR) up to 7 years in patients with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) enrolled in clinical trials or treated in real-world postmarketing settings. [...]
2021 - 10.1212/WNL.0000000000012700
Neurology, Vol. 97 Núm. 16 (october 2021) , p. E1546-E1559  
Detailed record - Creative Commons
15.
8 p, 915.8 KB Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis / Leist, Thomas (Jefferson University) ; Cook, S. (New Jersey Medical School) ; Comi, Giancarlo (Università Vita-Salute San Raffaele) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Giovannoni, Gavin (Queen Mary University of London) ; Nolting, A. (Merck KGaA) ; Damian, D. (Merck KGaA) ; Syed, S. (Merck KGaA) ; Galazka, Andrew (Merck KGaA) ; Universitat Autònoma de Barcelona
Background: Long-term safety data are of particular interest for any newly approved treatment in multiple sclerosis such as cladribine tablets 10 mg (MAVENCLAD®; 3. 5 mg/kg cumulative dose over 2 years, referred to as cladribine tablets 3. [...]
2020 - 10.1016/j.msard.2020.102572
Multiple Sclerosis and Related Disorders, Vol. 46 (november 2020) , p. 102572  
Detailed record - Creative Commons
16.
10 p, 683.9 KB Ozanimod in relapsing multiple sclerosis : Pooled safety results from the clinical development program / Selmaj, Krzysztof W. (University of Warmia and Mazury) ; Cohen, Jeffrey A. (Neurological Institute) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Bar-Or, Amit (University of Pennsylvania) ; Arnold, Douglas Lorne (McGill University) ; Steinman, Lawrence (Stanford University Medical Center) ; Hartung, Hans-Peter (Medical University Vienna) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Kubala Havrdova, Eva (Charles University) ; Cree, Bruce A. C (UCSF University of California San Francisco) ; Minton, Neil (Bristol Myers Squibb) ; Sheffield, James K. (Bristol Myers Squibb) ; Ding, Ning (Bristol Myers Squibb) ; Kappos, Ludwig (University of Basel) ; Universitat Autònoma de Barcelona
Background: Ozanimod, an oral sphingosine 1-phosphate receptor 1 and 5 modulator, is approved in multiple countries for the treatment of relapsing multiple sclerosis (RMS). In phase 3 trials, ozanimod was well tolerated and superior to interferon beta-1a 30 µg once-weekly in reducing clinical and radiologic disease activity. [...]
2021 - 10.1016/j.msard.2021.102844
Multiple Sclerosis and Related Disorders, Vol. 51 (june 2021) , p. 102844  
Detailed record - Creative Commons
17.
10 p, 1.0 MB Immunosenescence in multiple sclerosis : the identification of new therapeutic targets / Dema, María (Hospital Universitari Vall d'Hebron) ; Eixarch, Herena (Hospital Universitari Vall d'Hebron) ; Villar, Luisa M. (Hospital Universitario Ramón y Cajal (Madrid)) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Espejo, Carmen (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase in the life expectancy of the general population and the availability of effective disease-modifying treatments. [...]
2021 - 10.1016/j.autrev.2021.102893
Autoimmunity Reviews, Vol. 20 Núm. 9 (september 2021) , p. 102893  
Detailed record - Creative Commons
18.
10 p, 761.4 KB XIII Reunión Post-ECTRIMS: Revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II) / Fernández Fernández, Óscar (Hospital Regional Universitario de Málaga) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Aladro, Yolanda (Hospital Universitario de Getafe (Madrid)) ; Alonso, Ana (Hospital Regional Universitario de Málaga) ; Arroyo, Rafael (Arroyo González) (Hospital Universitario Quirónsalud (Pozuelo, Madrid)) ; Calles, Carmen (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Castillo-Triviño, Tamara (Hospital de Donostia (Sant Sebastià, País Basc)) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Costa-Frossard, Lucienne (Hospital Universitario Ramón y Cajal (Madrid)) ; Forero, Lucía (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ; Ginestal, Ricardo (Hospital Universitario Clínico de Madrid) ; Landete Pascual, Lamberto (Hospital Universitari Doctor Peset (València)) ; Llaneza González, Miguel (Complejo Hospitalario Universitario de Ferrol) ; Llufriu, Sara (Hospital Clínic i Provincial de Barcelona) ; Martínez-Ginés, María Luisa (Hospital General Universitario Gregorio Marañón) ; Meca-Lallana, Jose Eustasio (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ; Mendibe Bilbao, María del Mar (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Oreja-Guevara, Celia (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Oterino, Agustín (Hospital Universitario Central de Asturias) ; Prieto González, José María (Complejo Hospitalario Universitario de Santiago de Compostela) ; Ramió-Torrentà, Lluís (Institut d'Investigació Biomèdica de Girona) ; Romero-Pinel, Lucía (Hospital Universitari de Bellvitge) ; Téllez Lara, Nieves (Hospital Clínico Universitario de Valladolid) ; Rodríguez-Antigüedad, Alfredo (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Universitat Autònoma de Barcelona. Departament de Medicina
Introducción: Desde hace más de una década, tras el Congreso ECTRIMS, se celebra en España la reunión post-ECTRIMS, donde neurólogos expertos en esclerosis múltiple (EM) se reúnen para revisar las novedades presentadas en el ECTRIMS. [...]
Introduction. For more than a decade, after the ECTRIMS Congress, Spain has hosted the Post-ECTRIMS meeting, where neurologists with expertise in multiple sclerosis (MS) meet to review the new developments presented at the ECTRIMS. [...]
2021 - 10.33588/RN.7212.2021173
Revista de neurología, Vol. 72 Núm. 12 (16 2021) , p. 433-442
2 documents
Detailed record - Creative Commons
19.
10 p, 391.9 KB Ponesimod Compared with Teriflunomide in Patients with Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study : A Randomized Clinical Trial / Kappos, Ludwig (University of Basel) ; Fox, Robert J. (Cleveland Clinic) ; Burcklen, Michel (Actelion Pharmaceuticals) ; Freedman, Mark S. (University of Ottawa) ; Kubala Havrdova, Eva (Charles University) ; Hennessy, Brian (Actelion Pharmaceuticals) ; Hohlfeld, Reinhard (Ludwig Maximilians University Munich) ; Lublin, Fred (Icahn School of Medicine at Mount Sinai) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Pozzilli, Carlo (Sapienza University of Rome) ; Scherz, Tatiana (Actelion Pharmaceuticals) ; D'Ambrosio, Daniele (Galapagos GmbH) ; Linscheid, Philippe (Actelion Pharmaceuticals) ; Vaclavkova, Andrea (Actelion Pharmaceuticals) ; Pirozek-Lawniczek, Magdalena (Actelion Pharmaceuticals) ; Kracker, Hilke (Actelion Pharmaceuticals) ; Sprenger, Till (University of Basel) ; Universitat Autònoma de Barcelona
Importance: To our knowledge, the Oral Ponesimod Versus Teriflunomide In Relapsing Multiple Sclerosis (OPTIMUM) trial is the first phase 3 study comparing 2 oral disease-modifying therapies for relapsing multiple sclerosis (RMS). [...]
2021 - 10.1001/jamaneurol.2021.0405
JAMA Neurology, Vol. 78 Núm. 5 (may 2021) , p. 558-567  
Detailed record - Creative Commons
20.
4 p, 256.0 KB Multiple sclerosis and nutrition : back to the future? / Gold, Ralf (St. Josef Hospital) ; Montalban, Xavier (Universitat Autònoma de Barcelona) ; Haghikia, Aiden (St. Josef Hospital)
2020 - 10.1177/1756286420936165
Therapeutic Advances in Neurological Disorders, Vol. 13 (2020)  
Detailed record - Creative Commons

Articles : 109 records found   previous11 - 20nextend  jump to record:
See also: similar author names
1 Montalban, X
1 Montalban, X
18 Montalban, X.
7 Montalban, Xavier,
18 Montalbán, X.
124 Montalbán, Xavier
7 Montalbán, Xavier,
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with